Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by ESMO Open
Adjuvant Endocrine Therapy Choices in Premenopausal Patients With HR-Positive Early Breast Cancer
Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
Dual Functionality of Tocilizumab as a Treatment for ICI-Associated Arthritis and as a Prophylactic Agent During ICI Rechallenge
Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
Recent and Projected Incidence Trends and Risk of Anal Cancer Among People With HIV in North America
Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
Single-Fraction Partial Breast Irradiation With Delayed Surgery for Low-Risk Breast Cancer
Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
Single-Fraction Preoperative Partial Breast Irradiation for Low-Risk Breast Cancer
Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
Long-Term HRQoL Outcomes of Adjuvant Pembrolizumab vs Placebo in Patients With Resected Stage III Melanoma
Disclosures Article Citation Disclosure statements are available on the authors' profiles: The Lancet Oncology From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
ESMO 2024: Neoadjuvant Tislelizumab Improves Coughing, Chest Pain in Resectable NSCLC
Open GPT Console Open Oracle Keywords Refresh Values Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes center of excellence alarm bookmark calendar check-clipboard clockwise compass-navigate compass counterclockwise delete download-book education-history email get-help gizmo-flag help-icon journal left link lock...
Clinicopathological and Molecular Data and Outcomes of MET Inhibitors in NSCLC With MET Exon 14 Skipping Mutations
Open GPT Console Open Oracle Keywords Refresh Values Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes center of excellence alarm bookmark calendar check-clipboard clockwise compass-navigate compass counterclockwise delete download-book education-history email get-help gizmo-flag help-icon journal left link lock...
Chemotherapy and PD-1/PD-L1 Inhibitor Combinations for TKI-Resistant EGFR-Mutated NSCLC
Open GPT Console Open Oracle Keywords Refresh Values Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes center of excellence alarm bookmark calendar check-clipboard clockwise compass-navigate compass counterclockwise delete download-book education-history email get-help gizmo-flag help-icon journal left link lock...
Interstitial Lung Disease in Patients Enrolled in Early-Phase Clinical Trials
Open GPT Console Open Oracle Keywords Refresh Values Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes center of excellence alarm bookmark calendar check-clipboard clockwise compass-navigate compass counterclockwise delete download-book education-history email get-help gizmo-flag help-icon journal left link lock...
High Health Care Utilization, Poor Survival Seen for Over 70s With AML
Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
Outcomes of First-Line Chemotherapy Plus Trastuzumab With or Without Bevacizumab for HER2/Neu-Positive MBC
Breast Cancer Research and Treatment A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105) From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Durvalumab Plus Chemoradiotherapy and Sequential Chemoradiotherapy Regimens for Stage III Unresectable NSCLC
Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
Breast Cancer Screening Attendance Helps Boost Other Cancer Screenings
Open GPT Console Open Oracle Keywords Refresh Values Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes center of excellence alarm bookmark calendar check-clipboard clockwise compass-navigate compass counterclockwise delete download-book education-history email get-help gizmo-flag help-icon journal left link lock...
Completion Axillary Lymph Node Dissection for Identifying pN2-3 Status as an Indication for Adjuvant CDK4/6 Inhibitor
Disclosures Article Citation Disclosure statements are available on the authors' profiles: The Lancet Oncology From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Biomarkers Associated With Pulmonary Exacerbations in a Randomized Trial of Nintedanib for Radiation Pneumonitis
Open GPT Console Open Oracle Keywords Refresh Values Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes center of excellence alarm bookmark calendar check-clipboard clockwise compass-navigate compass counterclockwise delete download-book education-history email get-help gizmo-flag help-icon journal left link lock...
Association of EBV DNA Load and Tumor Viral Lytic Genome With Outcomes in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma on Anti-PD-1 Monotherapy | PracticeUpdate
Disclosures Article Citation Disclosure statements are available on the authors' profiles: BMC Cancer From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Luspatercept vs Epoetin Alfa for Erythropoiesis-Stimulating Agent-Naïve, Transfusion-Dependent, Lower-Risk Myelodysplastic Syndromes
Disclosures Article Citation Disclosure statements are available on the authors' profiles: The Lancet Haematology From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Longitudinal ctDNA Analyses for Detecting Progression During Treatment in EGFR-Mutant Advanced NSCLC Before Radiologic Detection
Disclosures Article Citation Disclosure statements are available on the authors' profiles: Journal of Thoracic Oncology From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Delineating the Optimal Gene Set for Germline Testing in Patients With Population-Type Breast Cancer
Open GPT Console Open Oracle Keywords Refresh Values Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes center of excellence alarm bookmark calendar check-clipboard clockwise compass-navigate compass counterclockwise delete download-book education-history email get-help gizmo-flag help-icon journal left link lock...
Interpretable Artificial Intelligence to Optimise Imatinib Use After Resection in Localised Gastrointestinal Stromal Tumours
Disclosures Article Citation Disclosure statements are available on the authors' profiles: The Lancet Oncology From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intraperitoneal PD-1 Monoclonal Antibody for Advanced Primary Liver Cancer With Malignant Ascites
Open GPT Console Open Oracle Keywords Refresh Values Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes center of excellence alarm bookmark calendar check-clipboard clockwise compass-navigate compass counterclockwise delete download-book education-history email get-help gizmo-flag help-icon journal left link lock...
Sequencing Paired Tumor DNA and WBCs Improves ctDNA Tracking and Detects Pathogenic Germline Variants in Localized Colon Cancer
Open GPT Console Open Oracle Keywords Refresh Values Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes center of excellence alarm bookmark calendar check-clipboard clockwise compass-navigate compass counterclockwise delete download-book education-history email get-help gizmo-flag help-icon journal left link lock...
Safety of Pregnancy in Young Women After the Treatment of Hormone Receptor-Positive Breast Cancer
Open GPT Console Open Oracle Keywords Refresh Values Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes center of excellence alarm bookmark calendar check-clipboard clockwise compass-navigate compass counterclockwise delete download-book education-history email get-help gizmo-flag help-icon journal left link lock...
FDA Approves Voranigo for Grade 2 Astrocytoma or Oligodendroglioma
Open GPT Console Open Oracle Keywords Refresh Values Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes center of excellence alarm bookmark calendar check-clipboard clockwise compass-navigate compass counterclockwise delete download-book education-history email get-help gizmo-flag help-icon journal left link lock...
Quality-of-Life Outcomes in Patients With Metastatic Spinal Cord Compression
Open GPT Console Open Oracle Keywords Refresh Values Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes center of excellence alarm bookmark calendar check-clipboard clockwise compass-navigate compass counterclockwise delete download-book education-history email get-help gizmo-flag help-icon journal left link lock...
Authors | ESMO Open
Submit manuscript >> ESMO Open is an online-only, peer-reviewed, open access oncology journal published by BMJ on behalf of the European Society for Medical Oncology (ESMO). The journal aims to operate a fast submission process with continuous publication online, to ensure that timely, up-to-date research is available worldwide. The journal adheres to a rigorous and transparent peer review process.
Results of first study assessing clinical impact of ESMO-MCBS
LUGANO, 7 July 2016 - Details of the first study by one of Europe's largest cancer centres, the Medical University of Vienna (MUV), assessing the clinical impact and feasibility of the ESMO Magnitude of Clinical Benefit Scale (MCBS) in a real-life context are now available on ESMO Open(1).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with ESMO
Contact ESMO, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack